Federal Circuit Upholds Dismissal Of Amgen Patent Allegations
WASHINGTON, D.C. — A panel of the Federal Circuit U.S. Court of Appeals on July 29 affirmed dismissal by a federal judge in Delaware of patent infringement allegations stemming from an...To view the full article, register now.
Already a subscriber? Click here to view full article